Summit Therapeutics Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €2.20B +153.5% €606.40M -751.8% 27.5% +0.38 pp N/A N/A
    (estimated) €869.59M +748.2% -€93.03M -83.3% -10.7% +5.3 pp N/A N/A
    (estimated) €102.52M +1,291.7% -€555.78M -1.6% -542.1% +71 pp N/A N/A
    (estimated) €7.37M +∞% -€564.89M -34.5% -7,668.4% -77 pp N/A N/A
    (estimated) €0.00 +NaN% -€862.86M +352.0% N/A N/A N/A
    €0.00 +NaN% -€190.90M -64.0% N/A -€122.46M +85.3% N/A
    €0.00 -100.0% -€530.43M +680.5% N/A -€66.10M +87.1% N/A
    €607.52K -61.1% -€67.96M -11.1% -11,185.9% -63 pp -€35.33M -43.3% -5,815.5% -18 pp
    €1.56M +110.3% -€76.43M +68.1% -4,897.8% +12 pp -€62.35M +51.6% -3,995.6% +15 pp
    €741.83K +5.4% -€45.46M +65.4% -6,127.6% -22 pp -€41.14M +133.7% -5,545.3% -30 pp
    €704.03K -96.5% -€27.48M -16.3% -3,903.4% -37 pp -€17.60M -23.9% -2,500.5% -24 pp
    €20.13M +507.5% -€32.83M +33.5% -163.1% +5.8 pp -€23.14M -231.6% -115.0% -6.5 pp
    €3.31M +124.8% -€24.59M -12.2% -742.0% +12 pp €17.59M -162.7% 530.8% +24 pp
    €1.47M -43.5% -€28.00M +42.1% -1,899.8% -11 pp -€28.05M +43.3% -1,902.9% -12 pp
    €2.61M +0.0% -€19.70M +70.4% -754.9% -3.1 pp -€19.57M +77.1% -750.0% -3.3 pp
    €2.61M -20.8% -€11.56M +50.6% -443.1% -2.1 pp -€11.05M +95.4% -423.4% -2.5 pp
    €3.30M +3.4% -€7.68M +57.8% -232.9% -0.80 pp -€5.65M +35.9% -171.5% -0.41 pp
    €3.19M +129.7% -€4.87M -43.0% -152.6% +4.6 pp -€4.16M -12.6% -130.5% +2.1 pp
    €1.39M +299.7% -€8.54M -14.3% -614.9% +23 pp -€4.76M +65.3% -343.0% +4.9 pp
    €347.42K +13.2% -€9.96M -73.2% -2,867.1% +92 pp -€2.88M -80.8% -829.6% +41 pp
    €306.80K -95.6% -€37.15M +60.4% -12,109.6% -120 pp -€15.04M +6.6% -4,901.1% -47 pp
    €6.93M +197.1% -€23.16M +239.8% -334.1% -0.42 pp -€14.11M +374.0% -203.5% -0.76 pp
    €2.33M +113.9% -€6.82M +212.4% -292.1% -0.92 pp -€2.98M +3,194.0% -127.6% -1.2 pp
    €1.09M +345.5% -€2.18M +2,089.1% -200.0% -1.6 pp -€90.37K -76.7% -8.3% +1.5 pp
    €244.81K +11,561.4% -€99.66K +106.4% -40.7% +23 pp -€387.79K +18,372.6% -158.4% -0.58 pp
    €2.10K -€48.28K -2,300.0% -€2.10K -100.0%

    Notifications